On behalf of the Personalized Medicine Coalition, I am pleased to provide an update on the state of the Coalition two decades after its launch in 2004.
Some 20 institutions founded PMC based on the assumption that paradigm changes in medicine don’t happen just because science and new technologies suggest they should. Twenty years later, the steadfast support of more than 200 PMC members provides foundational ballast and strength for the Coalition’s programs in education, advocacy, and evidence development that documents the promise and potential of personalized medicine.
Membership revenues comprise about two-thirds of PMC’s annual budget. Bolstered by membership support, PMC spearheads robust and impactful advocacy activities in public and science policy. It also publishes multiple communications materials that help educate providers, policymakers, payers, and patients about the importance of personalized medicine.
This year, PMC is also raising funds to support its work on the 18th Annual Personalized Medicine Conference as well as a new Implementing Precision Oncology (IPO) initiative.
Building on PMC’s earlier work showing that diagnostic testing-informed treatment strategies are reaching fewer than 36 percent of advanced non-small cell lung cancer patients, the IPO initiative will begin with the creation of a Roadmap for Addressing Clinical Practice Gaps in Personalized Medicine and will continue with implementation pilot programs in future years. Designed to help close the gap between what is possible and what is practiced in modern medicine, the initiative promises to save lives and inspire investor confidence in the returns that can be gained from supporting companies focused on developing new tests and treatments to improve patient outcomes.
Opportunities are still available to sponsor PMC’s work on the conference and the IPO initiative this year. Any support that your institution can provide for either program will go a long way to further advance personalized medicine for the benefit of patients and health systems.
To provide support for PMC’s work in 2024 and learn more about our preliminary plans for 2025, I encourage you to contact the appropriate members of PMC’s leadership team.
